Che Xu

3.3k total citations · 1 hit paper
14 papers, 2.7k citations indexed

About

Che Xu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Che Xu has authored 14 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Che Xu's work include Peptidase Inhibition and Analysis (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Transplantation: Methods and Outcomes (2 papers). Che Xu is often cited by papers focused on Peptidase Inhibition and Analysis (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Transplantation: Methods and Outcomes (2 papers). Che Xu collaborates with scholars based in China, United States and Hong Kong. Che Xu's co-authors include Jinshun Pan, Ting Zhao, Xianmin Mu, Qiang You, Biao Geng, Chao Wang, Jiajia Shen, Jing Yang, Hu Shi and Wei Shi and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Che Xu

13 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endoplasmic reticulum stress: cell life and death decisions

2005 1.9k citations Che Xu Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Che Xu China	10	1.3k	1.1k	693	449	366	14	2.7k
Dariusz Pytel United States	22	1.2k 0.9×	1.1k 1.0×	679 1.0×	240 0.5×	223 0.6×	50	2.3k
Chi Li United States	25	2.5k 1.8×	801 0.7×	1.2k 1.8×	403 0.9×	429 1.2×	70	3.7k
Karen D. McCullough United States	8	1.3k 1.0×	1.3k 1.2×	678 1.0×	237 0.5×	191 0.5×	11	2.4k
Nobuhiko Hiramatsu Japan	28	1.1k 0.8×	1.1k 1.0×	627 0.9×	336 0.7×	165 0.5×	56	2.5k
Sanjeev Gupta Ireland	29	2.7k 2.0×	1.8k 1.6×	1.2k 1.7×	472 1.1×	382 1.0×	62	4.5k
Donna J. Thuerauf United States	34	2.5k 1.9×	1.9k 1.6×	986 1.4×	365 0.8×	258 0.7×	47	4.2k
Kunihiro Hayakawa Japan	26	931 0.7×	755 0.7×	470 0.7×	400 0.9×	176 0.5×	58	2.2k
Yanjun Ma United States	16	1.6k 1.2×	2.1k 1.9×	1.1k 1.5×	388 0.9×	157 0.4×	25	3.2k
Kenji Takehana Japan	17	2.1k 1.5×	726 0.6×	1.6k 2.3×	270 0.6×	268 0.7×	26	3.6k
Jeanho Yun South Korea	30	2.4k 1.8×	530 0.5×	889 1.3×	339 0.8×	402 1.1×	87	3.6k

Countries citing papers authored by Che Xu

Since Specialization

Citations

This map shows the geographic impact of Che Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Che Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Che Xu more than expected).

Fields of papers citing papers by Che Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Che Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Che Xu. The network helps show where Che Xu may publish in the future.

Co-authorship network of co-authors of Che Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Che Xu. A scholar is included among the top collaborators of Che Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Che Xu. Che Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wu, Zhihao, Mingjun Li, Che Xu, et al.. (2025). YiQiChuTan formula (YQCTF) inhibit the progression of non-small cell lung cancer via down-regulating EGFR/ITGB2 signaling: Triangulated evidence from network pharmacology, proteomic profiling, and experimental validation. Phytomedicine. 144. 156950–156950. 1 indexed citations

Xu, Che, Janet Lee, Jonathan K. Alder, et al.. (2021). Rapid postmortem ventilation improves donor lung viability by extending the tolerable warm ischemic time after cardiac death in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 321(4). L653–L662.

Zhang, Chen, Shi Xiao, Zhongping Su, et al.. (2021). CD36 deficiency ameliorates drug-induced acute liver injury in mice. Molecular Medicine. 27(1). 15 indexed citations

Wang, Xingan, E O’Brien, Che Xu, et al.. (2019). Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia–Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation. American Journal of Respiratory Cell and Molecular Biology. 61(2). 244–256. 38 indexed citations

Geng, Biao, Jinshun Pan, Ting Zhao, et al.. (2018). Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 208–208. 87 indexed citations

Wang, Chao, Chen Zhang, Xiang Li, et al.. (2018). CPT1A‐mediated succinylation of S100A10 increases human gastric cancer invasion. Journal of Cellular and Molecular Medicine. 23(1). 293–305. 109 indexed citations

Mu, Xianmin, Wei Shi, Yue Xu, et al.. (2018). Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer. Cell Cycle. 17(4). 428–438. 349 indexed citations

Mu, Xianmin, Ting Zhao, Che Xu, et al.. (2017). Oncometabolite succinate to promote angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation.. Journal of Clinical Oncology. 35(15_suppl). e23000–e23000. 4 indexed citations

Geng, Biao, Chao Wang, Ying Che, et al.. (2017). IκB-kinase-ε in the tumor microenvironment is essential for the progression of gastric cancer. Oncotarget. 8(43). 75298–75307. 10 indexed citations

10.

Mu, Xianmin, Ting Zhao, Che Xu, et al.. (2017). Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation. Oncotarget. 8(8). 13174–13185. 96 indexed citations

11.

Xu, Che, Chen Zhang, Jie Ji, et al.. (2017). CD36 deficiency attenuates immune‐mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10. Hepatology. 67(5). 1943–1955. 40 indexed citations

12.

Tan, Qian, Weiping Xie, Che Xu, et al.. (2011). Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases. 31(6). 1233–1242. 31 indexed citations

13.

Xu, Che. (2005). Endoplasmic reticulum stress: cell life and death decisions. Journal of Clinical Investigation. 115(10). 2656–2664. 1941 indexed citations breakdown →

14.

Xu, Che, et al.. (2000). The effects of recombinant RA538 and antisense c-myc adenovirus on tumor cells and the molecular mechanism concerned.. PubMed. 17(3). 164–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact